Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Harmonic Inc a un objectif de cours consensus de $11.67, basé sur les évaluations des 7 analystes. Le plus élevé est de $14 attribué par Raymond James le octobre 29, 2024, et le plus bas est de $8 attribué par Barclays le juillet 29, 2025. Les 3 dernières évaluations d'analystes ont été publiées par Barclays, Rosenblatt et Needham le juillet 29, 2025. Avec un objectif de cours moyen de $10.33 entre Barclays, Rosenblatt et Needham, il y a une variation implicite de 7.42% upside pour Harmonic Inc à partir de ces dernières évaluations d'analystes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/29/2025 | -16.84% | Barclays | $10 → $8 | Maintains | Equal-Weight | |||
07/29/2025 | 14.35% | Rosenblatt | $11 → $11 | Maintains | Buy | |||
07/29/2025 | 24.74% | Needham | $14 → $12 | Maintains | Buy | |||
07/08/2025 | — | Wolfe Research | — | Initiates | → Underperform | |||
06/17/2025 | 14.35% | Rosenblatt | $11 → $11 | Maintains | Buy | |||
04/29/2025 | 14.35% | Rosenblatt | $12 → $11 | Maintains | Buy | |||
04/29/2025 | 45.53% | Needham | $14 → $14 | Reiterates | Buy → Buy | |||
02/11/2025 | 24.74% | Rosenblatt | $16 → $12 | Maintains | Buy | |||
02/11/2025 | 3.95% | Barclays | $14 → $10 | Maintains | Equal-Weight | |||
02/11/2025 | 29.94% | Northland Capital Markets | $14 → $12.5 | Maintains | Outperform | |||
02/11/2025 | 45.53% | Needham | $18 → $14 | Maintains | Buy | |||
02/04/2025 | 66.32% | Rosenblatt | $16 → $16 | Maintains | Buy | |||
01/09/2025 | 45.53% | Barclays | $17 → $14 | Downgrade | Overweight → Equal-Weight | |||
10/29/2024 | 29.94% | Jefferies | $14 → $12.5 | Downgrade | Buy → Hold | |||
10/29/2024 | 66.32% | Rosenblatt | $18 → $16 | Maintains | Buy | |||
10/29/2024 | 76.72% | Barclays | $20 → $17 | Maintains | Overweight | |||
10/29/2024 | 45.53% | Northland Capital Markets | $16 → $14 | Maintains | Outperform | |||
10/29/2024 | 45.53% | Raymond James | $17 → $14 | Downgrade | Strong Buy → Outperform | |||
10/29/2024 | 87.11% | Needham | $18 → $18 | Reiterates | Buy → Buy | |||
10/15/2024 | 87.11% | Rosenblatt | $18 → $18 | Maintains | Buy | |||
07/30/2024 | 107.9% | Barclays | $14 → $20 | Maintains | Overweight | |||
07/30/2024 | 87.11% | Needham | $18 → $18 | Reiterates | Buy → Buy | |||
07/18/2024 | 87.11% | Rosenblatt | $18 → $18 | Maintains | Buy | |||
06/17/2024 | 87.11% | Needham | $18 → $18 | Reiterates | Buy → Buy | |||
05/17/2024 | 87.11% | Needham | $18 → $18 | Reiterates | Buy → Buy | |||
04/30/2024 | 87.11% | Needham | $18 → $18 | Reiterates | Buy → Buy | |||
04/17/2024 | 87.11% | Needham | $18 → $18 | Reiterates | Buy → Buy | |||
04/09/2024 | 87.11% | Needham | $18 → $18 | Reiterates | Buy → Buy | |||
01/30/2024 | 66.32% | Rosenblatt | $18 → $16 | Maintains | Buy | |||
01/30/2024 | 87.11% | Raymond James | $19 → $18 | Maintains | Strong Buy | |||
12/29/2023 | 87.11% | Rosenblatt | → $18 | Reiterates | Buy → Buy | |||
12/20/2023 | 87.11% | Needham | $18 → $18 | Reiterates | Buy → Buy | |||
12/14/2023 | 97.51% | Raymond James | $15 → $19 | Maintains | Strong Buy | |||
12/13/2023 | 97.51% | Raymond James | $15 → $19 | Maintains | Strong Buy | |||
11/01/2023 | 45.53% | Barclays | $20 → $14 | Maintains | Overweight | |||
10/31/2023 | 55.93% | Raymond James | $16 → $15 | Maintains | Strong Buy | |||
10/31/2023 | 87.11% | Needham | → $18 | Reiterates | Buy → Buy | |||
08/10/2023 | 66.32% | Raymond James | $15 → $16 | Upgrade | Outperform → Strong Buy | |||
08/01/2023 | 107.9% | Northland Capital Markets | $23 → $20 | Maintains | Outperform | |||
08/01/2023 | 55.93% | Raymond James | $17 → $15 | Maintains | Outperform | |||
08/01/2023 | 87.11% | Rosenblatt | $22 → $18 | Maintains | Buy | |||
08/01/2023 | 87.11% | Needham | $21 → $18 | Maintains | Buy | |||
08/01/2023 | 107.9% | Barclays | $23 → $20 | Maintains | Overweight | |||
07/21/2023 | 128.69% | Rosenblatt | → $22 | Reiterates | Buy → Buy | |||
06/09/2023 | 128.69% | Rosenblatt | → $22 | Reiterates | Buy → Buy | |||
06/06/2023 | 118.3% | Needham | → $21 | Reiterates | → Buy | |||
05/31/2023 | 128.69% | Rosenblatt | → $22 | Reiterates | Buy → Buy | |||
05/23/2023 | 118.3% | Needham | → $21 | Reiterates | Buy → Buy | |||
05/19/2023 | 118.3% | Needham | → $21 | Reiterates | Buy → Buy | |||
05/09/2023 | 128.69% | Rosenblatt | $20 → $22 | Maintains | Buy | |||
05/09/2023 | 118.3% | Needham | → $21 | Reiterates | → Buy | |||
05/09/2023 | 139.09% | Barclays | $20 → $23 | Maintains | Overweight | |||
04/14/2023 | 107.9% | Rosenblatt | → $20 | Reiterates | → Buy | |||
03/21/2023 | 139.09% | Northland Capital Markets | $20 → $23 | Maintains | Outperform | |||
03/21/2023 | 107.9% | Rosenblatt | → $20 | Reiterates | → Buy | |||
03/21/2023 | 97.51% | Needham | → $19 | Reiterates | → Buy | |||
02/17/2023 | 97.51% | Needham | → $19 | Maintains | Buy | |||
01/31/2023 | 76.72% | Raymond James | $18 → $17 | Maintains | Outperform | |||
01/31/2023 | 97.51% | Needham | → $19 | Reiterates | → Buy | |||
01/31/2023 | 107.9% | Barclays | $17 → $20 | Maintains | Overweight | |||
01/24/2023 | 97.51% | Needham | $17 → $19 | Maintains | Buy | |||
01/09/2023 | 97.51% | Jefferies | → $19 | Upgrade | Hold → Buy | |||
11/01/2022 | 87.11% | Raymond James | $13 → $18 | Maintains | Outperform | |||
11/01/2022 | 76.72% | Barclays | $14 → $17 | Maintains | Overweight | |||
10/19/2022 | 107.9% | Rosenblatt | $17 → $20 | Maintains | Buy | |||
09/16/2022 | 76.72% | Needham | $15 → $17 | Maintains | Buy |
Le dernier objectif de prix pour Harmonic (NASDAQ:HLIT) a été rapporté par Barclays le juillet 29, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $8.00 s'attendant à ce que HLIT se fall dans les 12 prochains mois (un possible changement de -16.84% downside). 20 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour Harmonic (NASDAQ:HLIT) a été fournie par Barclays, et Harmonic maintenu leur note equal-weight.
La dernière amélioration pour Harmonic Inc a eu lieu le août 10, 2023 lorsque Raymond James a augmenté leur objectif de prix à $16. Raymond James avait précédemment an outperform pour Harmonic Inc.
La dernière réduction pour Harmonic Inc a eu lieu le janvier 9, 2025 lorsque Barclays a changé leur objectif de prix de $17 à $14 pour Harmonic Inc.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Harmonic, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Harmonic a été déposée le juillet 29, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers juillet 29, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de Harmonic (HLIT) était un maintenu avec un objectif de prix de $10.00 à $8.00. Le prix actuel de Harmonic (HLIT) est de $9.62, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.